查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
IV水合治療市場 - 全球產業規模、佔有率、趨勢、機會和預測，2018-2028F 按服務、組件、最終用戶、地區和競爭細分
市場調查報告書
商品編碼
1348900

IV水合治療市場 - 全球產業規模、佔有率、趨勢、機會和預測，2018-2028F 按服務、組件、最終用戶、地區和競爭細分

IV Hydration Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Service, By Component, By End Users, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 176 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計全球IV水合治療市場在預測期內將出現令人印象深刻的成長。這可以歸因於慢性病發病率的增加、全球手術數量的增加以及靜脈注射藥物批准數量的增加。此外，預計提供靜脈注射療法的診所數量不斷增加，以增加公司的地理分佈，預計將在預測期內推動市場的成長。同樣，營養不良盛行率的上升、反應時間的縮短以及與靜脈溶液治療相關的更高的療效是多年來市場成長的主要驅動力。同樣，不接受任何其他形式營養的患者擴大採用營養，將進一步推動多年來市場的成長。此外，人口老化日益嚴重，患者需要透過靜脈注射途徑餵食營養必需的產品，這將進一步推動預測期內市場的成長。例如，2022年7月，主要檢測和健康提供者Sameday Health在美國推出了Inner Beauty IV點滴療法。該服務將在擁有健康設施的地區的Sameday Health診所提供，以幫助客戶補充膠原蛋白生產，強化指甲和頭髮，保持皮膚健康，並提供其他好處。

慢性病盛行率增加

慢性病盛行率的不斷上升是全球IV水合治療市場成長的關鍵驅動力。糖尿病、心血管疾病和癌症等慢性疾病會導致脫水和營養缺乏。IV水合療法通常用作控制這些疾病的症狀和併發症的補充療法。慢性病患者往往需要頻繁住院或門診治療，這可能會導致因疾病或治療本身而脫水。IV水合療法是快速有效補充液體和營養物質的有效方法，可降低併發症風險並改善患者預後。此外，IV水合療法可以幫助控制癌症患者化療和放療的副作用。這些治療會引起嚴重的噁心和嘔吐，導致脫水和營養不良。IV水合療法可以幫助控制這些副作用並改善患者的整體生活品質。隨著全球人口老化和慢性病盛行率持續增加，IV水合療法的需求預計將增加。這種成長不僅限於醫院和診所，IV水合療法已在水療中心、健身房甚至私人住宅等非醫療環境中變得流行。

市場概況
預測期 2024-2028
2022年市場規模 27.1億美元
2028年市場規模 40.6億美元
CAGR (2023-2028) 6.86%
成長最快的細分市場 能量補充品
最大的市場 北美洲

健康和預防性醫療保健日益普及

健康和預防性醫療保健的日益普及是全球IV水合治療市場成長的重要動力。隨著人們健康意識的增強，人們對預防性醫療保健和保持最佳健康的興趣日益濃厚。IV水合療法成為實現這一目標的流行方法。IV水合療法是增強免疫系統、補充液體和電解質以及改善整體健康的有效方法。它經常被運動員和健身愛好者用來幫助運動或比賽後恢復，以及提高表現。此外，IV水合療法也擴大被用作對抗老化影響的一種方法，包括疲勞、皺紋和其他老化跡象。它也用於對抗現代社會常見的壓力和倦怠的影響。靜脈補水療法作為一種對抗宿醉和時差反應的方法也越來越受歡迎，因為它可以快速補充身體水分並緩解症狀。隨著對預防性醫療保健和健康服務的需求持續成長，對IV水合療法的需求預計也會增加。這種成長也得益於水療中心和健身中心等非醫療環境中越來越多的使用。

對微創醫療的需求不斷成長

對微創醫療的需求不斷成長是全球IV水合治療市場成長的重要動力。微創醫療是指比傳統外科手術風險、疼痛和恢復時間更小的治療。IV水合療法是一種微創治療，可以提供快速有效的結果，同時將不適或停機時間降至最低。IV水合療法是一種非侵入性治療，包括透過靜脈將液體、電解質和營養物質直接注射到血液中。這使得這些物質能夠快速吸收，可以快速補充液體和營養並解決廣泛的健康問題。IV水合療法的微創性質使其成為想要避免手術或其他侵入性治療的患者的有吸引力的治療選擇。對於因噁心、嘔吐或其他消化問題而難以服用口服藥物或補充劑的患者來說，也是一個受歡迎的選擇。此外，IV水合療法可以在各種環境中進行，包括醫院、診所，甚至家庭環境，這使其成為患者方便的治療選擇。隨著微創醫療需求的持續成長，IV水合治療的需求也預計會增加。這種成長不僅限於醫療環境，因為IV水合療法在水療中心、健身房和私人住宅等非醫療環境中也越來越流行。

在非醫療環境中擴大採用IV水合療法

在非醫療環境中擴大採用IV水合療法是全球IV水合療法市場成長的重要動力。IV水合療法不再局限於醫院和診所，而是成為水療中心、健身中心甚至私人住宅等非醫療環境中流行的治療選擇。在非醫療環境中擴大採用IV水合療法的原因之一是健康和預防性醫療保健的日益普及。在非醫療環境中擴大採用IV水合療法的另一個原因是便利因素。患者可以在運動或放鬆時在水療中心或健身中心接受IV水合治療，使其成為一種方便有效的治療方式。此外，行動IV水合治療服務的可用性不斷增加，也推動了IV水合治療在非醫療環境中的採用。這些服務直接為患者提供IV水合治療，無論患者在家中或偏遠地區，使其更加方便和容易獲得。在非醫療環境中擴大採用IV水合療法預計將繼續推動全球IV水合療法市場的成長。隨著越來越多的人意識到IV水合療法的好處以及在非醫療環境中接受治療的便利性，對這些服務的需求預計將進一步增加。

使用IV水合療法治療 COVID-19

使用IV水合療法作為 COVID-19 的治療方法預計將顯著影響全球IV水合療法市場的成長。 COVID-19是一種由新型冠狀病毒引起的呼吸道疾病，它會導致一些患者脫水和電解質失衡，尤其是重症患者。IV水合療法是治療 COVID-19 的潛在方法，因為它可以幫助解決脫水和電解質失衡問題，進一步改善整體健康並幫助復原。它還可用於提供有助於增強免疫系統和對抗病毒的藥物和補充劑。此外，IV水合療法已用於治療患有其他呼吸道疾病（例如流感和肺炎）的患者，並且在某些情況下已證明可以改善預後。隨著 COVID-19 大流行繼續在全球蔓延，作為該疾病潛在治療方法的IV水合療法的需求預計將會增加。這可能會導致IV水合療法的研發投資增加，特別是針對 COVID-19 的治療。此外，擴大使用IV水合療法治療 COVID-19 可能會導致醫療機構更多地採用該療法，甚至可能推動IV水合治療服務擴展到非醫療機構。

人口老化加劇

人口老化預計將顯著影響全球靜脈輸液治療市場的成長。隨著年齡的成長，他們的身體吸收營養和液體的效率會降低，導致脫水和其他健康問題。IV水合療法是解決老年患者常見脫水和營養缺乏問題的潛在解決方案。IV水合療法可以快速有效地將液體、電解質和其他必需營養素直接輸送到血液中，繞過消化系統並確保快速吸收。此外，隨著老年人口的成長，對家庭醫療保健服務的需求不斷增加，其中包括IV水合療法。許多老年患者喜歡在自己舒適的家中接受醫療服務，而行動靜脈輸液治療服務可以提供這種選擇。此外，老年人口更有可能患有癌症、腎臟病和心臟病等慢性疾病，因此增加了靜脈補水療法作為治療方案一部分的需求。總體而言，不斷成長的老齡化人口預計將推動IV水合療法的需求，作為老年患者脫水和營養缺乏的解決方案。這種需求可能會導致專門針對所有人口的IV水合治療的研究投資增加和不斷發展，以及IV水合治療服務不斷擴展到家庭醫療保健環境。

近期發展

  • 2020年，DripDrop ORS 是一種口服補液溶液，目的是為因疾病、運動或其他因素而脫水的人提供水合作用和電解質。本產品有多種口味可供選擇，可在網路上或指定零售店購買。
  • 2022年，Vida-Flo Hydration Station將成為一項特許經營的IV水合治療服務，為美國各地的客戶提供按需IV水合治療。該服務提供一系列靜脈輸液治療選項，包括注射維生素的靜脈注射和增強免疫力的靜脈注射。
  • 2020年，Nuun 運動電解質片目的是為運動員和活躍人士提供水分和電解質。這些藥片溶於水，可以在運動前、運動中或運動後服用，以幫助維持水合和電解質平衡。
  • 2020年，Reviv Global 成為一家全球特許經營的IV水合治療服務公司，為世界各地的客戶提供隨選IV水合治療。該服務提供一系列靜脈輸液治療選項，包括注射維生素的靜脈注射和增強免疫力的靜脈注射。
  • 2020年，Essential Elements Hydration粉是一種粉末狀電解質補充劑，目的是為因疾病、運動或其他因素而脫水的人提供水合和電解質。本產品有多種口味可供選擇，可在網路上或指定零售店購買。

市場區隔

全球IV水合治療市場可以按服務、組件、最終用戶和地區進行細分。根據服務，市場可分為免疫增強劑、能量增強劑、皮膚護理等。根據組成，市場可分為緊急醫療保健和常規醫療保健。根據最終用戶，市場可分為醫院和診所、健康中心和水療中心、家庭醫療保健等。

市場參與者

CCore Iv Therapy, LLC., Cryojuvenate Uk Ltd., B. Braun Melsungen Ag., Pfizer, Inc., Jw Life Science., Amanta Healthcare., Vifor Pharma Management Ltd., Otsuka Pharmaceutical Co., Ltd., Baxter., ICU MEDICAL.是全球IV水合治療市場的一些領先參與者。

報告範圍：

在本報告中，除了以下詳細介紹的產業趨勢外，全球IV水合治療市場還分為以下幾類：

IV水合治療市場，依服務分類：

  • 免疫增強劑
  • 能量補充品
  • 皮膚護理
  • 其他

IV水合治療市場，依組成部分：

  • 緊急醫療保健
  • 日常保健

IV水合治療市場，依最終使用者分類：

  • 醫院和診所
  • 健康中心和水療中心
  • 家庭醫療保健
  • 其他

IV水合治療市場，按地區：

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

競爭格局

公司概況：全球IV水合治療市場主要公司的詳細分析。

可用的客製化：

根據給定的市場資料，TechSci Research 可根據公司的具體需求提供客製化服務。本報告可以使用以下自訂選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第1章 產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第2章 研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 資料三角測量與驗證
  • 假設和限制

第3章 執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第4章 客戶之聲

第5章 全球IV水合療法市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依服務分類（免疫增強劑、能量增強劑、皮膚護理、偏頭痛、其他）
    • 按組成（藥物、非藥物）
    • 最終使用者（醫院和診所、健康中心和水療中心、家庭醫療保健、其他）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司分類 (2022)
  • 市場地圖
    • 按服務
    • 按組件
    • 按最終用戶
    • 按地區

第6章 北美IV水合療法市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按服務
    • 按組件
    • 按最終用戶
    • 按國家
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章 歐洲IV水合療法市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按服務
    • 按組件
    • 按最終用戶
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章 亞太地區IV水合治療市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按服務
    • 按組件
    • 按最終用戶
    • 按國家
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章 南美洲IV水合療法市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按服務
    • 按組件
    • 按最終用戶
    • 按國家
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章 中東和非洲IV水合療法市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按服務
    • 按組件
    • 按最終用戶
    • 按國家
  • MEA：國家分析
    • 南非IV水合療法
    • 沙烏地阿拉伯IV水合療法
    • 阿拉伯聯合大公國IV水合療法

第11章 市場動態

  • 動力
  • 挑戰

第12章 市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第13章 全球IV水合治療市場：SWOT 分析

第14章 波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章 競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT分析
    • Core Iv Therapy, Llc.
    • Cryojuvenate Uk Ltd.
    • B. Braun Melsungen Ag.
    • Pfizer, Inc.
    • Jw Life Science.
    • Amanta Healthcare.
    • Vifor Pharma Management Ltd.
    • Otsuka Pharmaceutical Co., Ltd.
    • Baxter.
    • ICU MEDICAL.

第16章 策略建議

第17章 關於我們與免責聲明

簡介目錄
Product Code: 15343

Global IV Hydration Therapy market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the increasing number of incidences of chronic diseases, growing number of surgeries across the globe, and rising number of intravenous drug approvals. Also, increasing establishments of clinics offering IV therapies to increase the geographical presence of the companies is anticipated to drive the growth of the market during the forecast period. Similarly, rising prevalence of malnutrition, shorter response time, and higher efficacy associated with intravenous solution therapy are the major drivers for the growth of the market over the years. Similarly, growing adoption of nutrition for patients who do not receive any other form of nutrition, will further propel the growth of the market over the years. Additionally, an increasing aging population where patients need to be fed nutritionally necessary products via intravenous routes will further drive the growth of the market during the forecast period. For instance, in July 2022, Sameday Health, a major testing & wellness provider, introduced the Inner Beauty IV drip therapy in the U.S. The service will be provided at Sameday Health clinics in the region where the wellness facilities are offered to help clients' collagen production, strengthen their nails and hair, keep their skin healthy, and provide other benefits.

Increasing Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases is a key driver of the growth of the Global IV Hydration Therapy market. Chronic diseases such as diabetes, cardiovascular diseases, and cancer, can cause dehydration and nutrient deficiencies. IV hydration therapy is often used as a complementary therapy to manage the symptoms and complications of these diseases. Patients with chronic diseases often require frequent hospitalizations or outpatient treatments, which can lead to dehydration due to the illness or the treatments themselves. IV hydration therapy is an effective way to replenish fluids and nutrients quickly and efficiently, reducing the risk of complications and improving patient outcomes. Additionally, IV hydration therapy can help manage the side effects of chemotherapy and radiation therapy in cancer patients. These treatments can cause severe nausea and vomiting, leading to dehydration and malnutrition. IV hydration therapy can help manage these side effects and improve the patient's overall quality of life. As the global population ages and the prevalence of chronic diseases continues to increase, the demand for IV hydration therapy is expected to grow. This growth is not just limited to hospitals and clinics, as IV hydration therapy has become popular in non-medical settings such as spas, gyms, and even private homes.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 2.71 Billion
Market Size 2028USD 4.06 Billion
CAGR (2023-2028)6.86%
Fastest Growing SegmentEnergy Boosters
Largest MarketNorth America

Rising Popularity of Wellness and Preventative Healthcare

The rising popularity of wellness and preventative healthcare is a significant driver of the growth of the Global IV Hydration Therapy Market. As people become more health-conscious, there is a growing interest in preventative healthcare and maintaining optimal health. IV hydration therapy is becoming a popular way to achieve this goal. IV hydration therapy is an effective way to boost the immune system, replenish fluids and electrolytes, and improve overall health and wellness. It is often used by athletes and fitness enthusiasts to aid in recovery after a workout or competition, as well as to improve performance. In addition, IV hydration therapy is increasingly being used as a way to combat the effects of aging, including fatigue, wrinkles, and other signs of aging. It is also used to combat the effects of stress and burnout, which are common in modern society. IV hydration therapy is also gaining popularity as a way to combat hangovers and jet lag, as it can quickly rehydrate the body and alleviate symptoms. As the demand for preventative healthcare and wellness services continues to grow, the demand for IV hydration therapy is expected to increase as well. This growth is also aided by the growing use in non-medical settings such as spas and fitness centers.

Growing Demand For Minimally Invasive Medical Treatments

The growing demand for minimally invasive medical treatments is a significant driver of the growth of the Global IV Hydration Therapy Market. Minimally invasive medical treatments are those that involve less risk, pain, and recovery time than traditional surgical procedures. IV hydration therapy is a minimally invasive treatment that can provide fast and effective results with minimal discomfort or downtime. IV hydration therapy is a non-invasive treatment that involves administering fluids, electrolytes, and nutrients directly into the bloodstream through a vein. This allows for rapid absorption of these substances, which can quickly replenish fluids and nutrients and address a wide range of health issues. The minimally invasive nature of IV hydration therapy makes it an attractive treatment option for patients who want to avoid surgery or other invasive treatments. It is also a popular choice for patients who have difficulty taking oral medications or supplements due to nausea, vomiting, or other digestive issues. Additionally, IV hydration therapy can be administered in a variety of settings, including hospitals, clinics, and even in-home settings, which makes it a convenient treatment option for patients. As the demand for minimally invasive medical treatments continues to grow, the demand for IV hydration therapy is expected to increase as well. This growth is not limited to medical settings, as IV hydration therapy is also becoming popular in non-medical settings such as spas, gyms, and private homes.

Increasing Adoption of IV Hydration Therapy in Non-Medical Settings

The increasing adoption of IV hydration therapy in non-medical settings is a significant driver in the growth of the Global IV Hydration Therapy market. IV hydration therapy is no longer limited to hospitals and clinics but is becoming a popular treatment option in non-medical settings such as spas, fitness centers, and even private homes. One reason for the increasing adoption of IV hydration therapy in non-medical settings is the growing popularity of wellness and preventative healthcare. Another reason for the increasing adoption of IV hydration therapy in non-medical settings is the convenience factor. Patients can receive IV hydration therapy in a spa or fitness center while they work out or relax, making it a convenient and efficient way to receive treatment. Additionally, the adoption of IV hydration therapy in non-medical settings is being driven by the increasing availability of mobile IV hydration therapy services. These services bring IV hydration therapy directly to patients, whether they are at home or at a remote location, making it even more convenient and accessible. The increasing adoption of IV hydration therapy in non-medical settings is expected to continue to drive the growth of the Global IV Hydration Therapy market. As more people become aware of the benefits of IV hydration therapy and the convenience of receiving treatment in non-medical settings, the demand for these services is expected to increase further.

Use of IV Hydration Therapy as a Treatment For COVID-19

The use of IV hydration therapy as a treatment for COVID-19 is expected to significantly influence the growth of the Global IV Hydration Therapy market. COVID-19 is a respiratory illness caused by the novel coronavirus, and it can cause dehydration and electrolyte imbalances in some patients, particularly in those with severe cases. IV hydration therapy is a potential treatment for COVID-19 because it can help to address dehydration and electrolyte imbalances, further improving overall health and aiding in recovery. It can also be used to deliver medications and supplements that can help to boost the immune system and fight the virus. In addition, IV hydration therapy has been used to treat patients with other respiratory illnesses, such as influenza and pneumonia, and has been shown to improve outcomes in some cases. As the COVID-19 pandemic continues to spread globally, the demand for IV hydration therapy as a potential treatment for the disease is expected to increase. This is likely to lead to increased investment in research and development of IV hydration therapy, specifically for the treatment of COVID-19. Furthermore, the increasing use of IV hydration therapy for COVID-19 treatment is likely to lead to increased adoption of the therapy in medical settings and may even drive the expansion of IV hydration therapy services into non-medical settings.

Growing Aging Population

The growing aging population is expected to significantly influence the growth of the Global IV Hydration Therapy market. As people age, their bodies become less efficient at absorbing nutrients and fluids, leading to dehydration and other health issues. IV hydration therapy is a potential solution for dehydration and nutrient deficiencies that are common in elderly patients. IV hydration therapy can quickly and efficiently deliver fluids, electrolytes, and other essential nutrients directly into the bloodstream, bypassing the digestive system and ensuring rapid absorption. Furthermore, as the elderly population grows, there is an increasing demand for home healthcare services, which can include IV hydration therapy. Many elderly patients prefer to receive healthcare services in the comfort of their own homes, to which mobile IV hydration therapy services can provide this option. In addition, the elderly population is more likely to suffer from chronic illnesses such as cancer, kidney disease, and heart disease, thereby increasing the need for IV hydration therapy as part of their treatment regimen. Overall, the growing aging population is expected to drive the demand for IV hydration therapy as a solution for dehydration and nutrient deficiencies in elderly patients. This demand is likely to lead to increased investment in research and growing development of IV hydration therapy specifically for all population and the growing expansion of IV hydration therapy services into home healthcare settings.

Recent Development

  • In 2020, DripDrop ORS is an oral rehydration solution that is designed to provide hydration and electrolytes to people who are dehydrated due to illness, exercise, or other factors. The product is available in a range of flavors and can be purchased online or in select retail stores.
  • In 2022, Vida-Flo Hydration Station is a franchise-based IV hydration therapy service that provides on-demand IV hydration therapy to customers at various locations across the United States. The service offers a range of IV hydration therapy options, including vitamin-infused IVs and immune-boosting IVs.
  • In 2020, Nuun Sport Electrolyte Tablets are designed to provide hydration and electrolytes to athletes and active individuals. The tablets dissolve in water and can be consumed before, during, or after exercise to help maintain hydration and electrolyte balance.
  • In 2020, Reviv Global is a global franchise-based IV hydration therapy service that provides on-demand IV hydration therapy to customers at various locations around the world. The service offers a range of IV hydration therapy options, including vitamin-infused IVs and immune-boosting IVs.
  • In 2020, Essential Elements Hydration Powder is a powder-based electrolyte supplement that is designed to provide hydration and electrolytes to people who are dehydrated due to illness, exercise, or other factors. The product is available in a range of flavors and can be purchased online or in select retail stores.

Market Segmentation

Global IV Hydration Therapy market can be segmented by Service, Component, End Users, and by Region. Based on Service, the market can be segmented into Immune Booster, Energy Booster, Skin Care, and Others. Based on Component, the market can be divided into Emergency Healthcare and Routine Healthcare. Based on End Users, the market can be segmented into Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, and Others.

Market Players

Core Iv Therapy, LLC., Cryojuvenate Uk Ltd., B. Braun Melsungen Ag., Pfizer, Inc., Jw Life Science., Amanta Healthcare., Vifor Pharma Management Ltd., Otsuka Pharmaceutical Co., Ltd., Baxter., ICU MEDICAL. are some of the leading players operating in the Global IV Hydration Therapy Market.

Report Scope:

In this report, Global IV Hydration Therapy market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

IV Hydration Therapy Market, By Service:

  • Immune Booster
  • Energy Boosters
  • Skin Care
  • Others

IV Hydration Therapy Market, By Component:

  • Emergency Healthcare
  • Routine Healthcare

IV Hydration Therapy Market, By End Users:

  • Hospitals & Clinics
  • Wellness Centers & Spa
  • Home Healthcare
  • Others

IV Hydration Therapy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global IV Hydration Therapy Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global IV Hydration Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Migraine, Others)
    • 5.2.2. By Component (Medicated, Non-Medicated)
    • 5.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Service
    • 5.3.2 By Component
    • 5.3.3 By End Users
    • 5.3.4 By Region

6. North America IV Hydration Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Component
    • 6.2.3. By End Users
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States IV Hydration Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Component
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada IV Hydration Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Component
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico IV Hydration Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Component
        • 6.3.3.2.3. By End User

7. Europe IV Hydration Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Component
    • 7.2.3. By End Users
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France IV Hydration Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Component
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany IV Hydration Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Component
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom IV Hydration Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Component
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy IV Hydration Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Component
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain IV Hydration Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Component
        • 7.3.5.2.3. By End User

8. Asia-Pacific IV Hydration Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Component
    • 8.2.3. By End Users
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China IV Hydration Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Component
        • 8.3.1.2.3. By End User
    • 8.3.2. India IV Hydration Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Component
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan IV Hydration Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Component
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea IV Hydration Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Component
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia IV Hydration Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Component
        • 8.3.5.2.3. By End User

9. South America IV Hydration Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Component
    • 9.2.3. By End Users
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil IV Hydration Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Component
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina IV Hydration Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Component
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia IV Hydration Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Component
        • 9.3.3.2.3. By End User

10. Middle East and Africa IV Hydration Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Component
    • 10.2.3. By End Users
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa IV Hydration Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Component
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia IV Hydration Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Component
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE IV Hydration Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Component
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global IV Hydration Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Core Iv Therapy, Llc.
    • 15.6.2 Cryojuvenate Uk Ltd.
    • 15.6.3 B. Braun Melsungen Ag.
    • 15.6.4 Pfizer, Inc.
    • 15.6.5 Jw Life Science.
    • 15.6.6 Amanta Healthcare.
    • 15.6.7 Vifor Pharma Management Ltd.
    • 15.6.8 Otsuka Pharmaceutical Co., Ltd.
    • 15.6.9 Baxter.
    • 15.6.10 ICU MEDICAL.

16. Strategic Recommendations

17. About Us & Disclaimer